Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > NY Providers > Hematologists

Dr. Scott Tagawa, MD, MS, FACP

Accepting New Patients

(Scott T. Tagawa, M.D., MS, FACP, FASCO)

(No ratings)

Specializes in: Hematology (Blood Disorders) and Medical Oncology

University of Southern California (USC), Keck School of Medicine

Professional interests include: thrombosis (blood clots), kidney cancer, genitourinary cancer, and more.

525 East 68th Street Starr 900
New York, NY 10065

(646) 962-2072

Dr. Scott Tagawa, MD, MS, FACP is a hematologist in New York, NY specializing in hematology (blood disorders) and medical oncology. He graduated from University of Southern California (USC), Keck School of Medicine. Dr. Scott Tagawa, MD, MS, FACP is affiliated with NewYork-Presbyterian, WEILL MEDICAL COLLEGE OF CORNELL and Multidisciplinary Prostate Cancer Clinic.

Office Locations

Address:

525 East 68th Street Starr 900
New York, NY 10065

Address:

520 East 70th Street Starr Pavilion, 3rd Floor
New York, NY 10021

In The News

“Poster presentations will focus on two ongoing clinical studies, a trials-in-progress update from NCT04506567, and a data update from NCT04946370, that are both currently investigating CONV01-a...”—"Cision PR Newswire", WIVB, February 2023

“The poster presentation of the data was by Dr. Scott Tagawa, a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member.”—"AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591", Oneida Dispatch, June 2021

“"In this patient population, which was not as heavily pre-treated as the population studied in the published randomized trials of 177 Lu-PSMA-617, PNT2002 was very well tolerated," said Scott...”—"POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022", Fox 5 San Diego, February 2016

doctor visit	916
hormone therapy	235
hospital care	57
inpatient care	57

**Gender**
Male	197
Female	48

**Ethnicity**
Non-Hispanic White	180
Black	29
Hispanic	22
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	120
From 75 to 84	83
85 and over	26
Less than 65	16

Hypertension	68
High Cholesterol	53
Stroke	5
Ischemic Heart Disease	44
Depression	19
Chronic Kidney Disease	39
Asthma	6
Osteoperosis	8
Atrial Fibrilation	7
Heart Failure	22
Chronic Obstructive Pulmonary Disease	9
Diabetes	33
Dementia	10
Cancer	73

doctor visit	959
hormone therapy	237
hospital care	147
inpatient care	147
preventive care	12
vaccines	12

**Gender**
Male	223
Female	75

**Ethnicity**
Non-Hispanic White	213
Black	24
Hispanic	33
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	138
From 75 to 84	105
85 and over	33
Less than 65	22

Hypertension	73
High Cholesterol	59
Stroke	5
Ischemic Heart Disease	51
Depression	24
Chronic Kidney Disease	46
Asthma	8
Osteoperosis	12
Atrial Fibrilation	12
Heart Failure	24
Chronic Obstructive Pulmonary Disease	10
Diabetes	34
Dementia	9
Cancer	73

doctor visit	962
hormone therapy	273
hospital care	139
inpatient care	139

**Gender**
Male	478
Female	102

**Ethnicity**
Non-Hispanic White	434
Black	56
Hispanic	50
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	238
From 75 to 84	228
85 and over	74
Less than 65	40

Hypertension	68
High Cholesterol	54
Stroke	5
Ischemic Heart Disease	51
Depression	22
Chronic Kidney Disease	41
Asthma	9
Osteoperosis	13
Atrial Fibrilation	12
Heart Failure	27
Chronic Obstructive Pulmonary Disease	10
Diabetes	29
Dementia	9
Cancer	75

doctor visit	1200
hormone therapy	376
hospital care	126
inpatient care	126

**Gender**
Male	263
Female	49

**Ethnicity**
Non-Hispanic White	250
Black	24
Hispanic	16
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	131
From 75 to 84	124
85 and over	40
Less than 65	17

Hypertension	63
High Cholesterol	53
Stroke	6
Ischemic Heart Disease	44
Depression	21
Chronic Kidney Disease	45
Asthma	13
Osteoperosis	8
Atrial Fibrilation	12
Heart Failure	27
Chronic Obstructive Pulmonary Disease	10
Diabetes	32
Dementia	13
Cancer	75

doctor visit	1117
hormone therapy	357
hospital care	107
inpatient care	107

**Gender**
Male	253
Female	44

**Ethnicity**
Non-Hispanic White	232
Black	28
Hispanic	16
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	120
From 75 to 84	119
85 and over	42
Less than 65	16

Hypertension	67
High Cholesterol	49
Stroke	6
Ischemic Heart Disease	45
Depression	26
Chronic Kidney Disease	43
Asthma	7
Osteoperosis	12
Atrial Fibrilation	12
Heart Failure	20
Chronic Obstructive Pulmonary Disease	11
Diabetes	30
Dementia	12
Cancer	75

doctor visit	1104
hormone therapy	351
hospital care	111
inpatient care	111

**Gender**
Male	283
Female	47

**Ethnicity**
Non-Hispanic White	262
Black	28
Hispanic	21
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	142
From 75 to 84	140
85 and over	36
Less than 65	12

Hypertension	71
High Cholesterol	59
Stroke	6
Ischemic Heart Disease	45
Depression	25
Chronic Kidney Disease	46
Asthma	8
Osteoperosis	14
Atrial Fibrilation	14
Heart Failure	20
Chronic Obstructive Pulmonary Disease	11
Diabetes	27
Dementia	12
Cancer	75

doctor visit	1059
hormone therapy	365
hospital care	118
inpatient care	118

**Gender**
Male	279
Female	40

**Ethnicity**
Non-Hispanic White	238
Black	27
Hispanic	20
Asian	12
Other	22
Native American	0

**Age**
From 65 to 74	146
From 75 to 84	109
85 and over	50
Less than 65	14

Hypertension	69
High Cholesterol	57
Stroke	7
Ischemic Heart Disease	47
Depression	0
Chronic Kidney Disease	49
Asthma	4
Osteoperosis	16
Atrial Fibrilation	13
Heart Failure	20
Chronic Obstructive Pulmonary Disease	13
Diabetes	32
Dementia	13
Cancer	75

doctor visit	1010
hormone therapy	161
hospital care	44
inpatient care	44

**Gender**
Male	278
Female	13

**Ethnicity**
Non-Hispanic White	232
Black	14
Hispanic	11
Asian	11
Other	23
Native American	0

**Age**
From 65 to 74	127
From 75 to 84	118
85 and over	35
Less than 65	11

Hypertension	67
High Cholesterol	58
Stroke	4
Ischemic Heart Disease	46
Depression	21
Chronic Kidney Disease	47
Asthma	5
Osteoperosis	13
Atrial Fibrilation	13
Heart Failure	20
Chronic Obstructive Pulmonary Disease	8
Diabetes	27
Dementia	10
Cancer	75

doctor visit	2099
hormone therapy	209
hospital care	70
inpatient care	70

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Scott Tagawa, MD, MS, FACP for Medicare patients.

The highest averages for the top procedures that Dr. Scott Tagawa, MD, MS, FACP treated as a hematologist in New York, NY were hormone therapy, hospital care, inpatient care and preventive care.

doctor visit	1159
hormone therapy	284
hospital care	102
inpatient care	102
preventive care	12
vaccines	12

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Scott Tagawa, MD, MS, FACP.

**Gender**
Male	225
Female	41

**Ethnicity**
Black / African American	23
Asian / Pacific Islander	2
Non-Hispanic White	204
Native American / Alaskan Native	0
Hispanic	18
Other	4

**Age**
75 to 84	102
85 and over	33
Less than 65	14
65 to 74	116

Average of Total of Conditions of Medicare patients treated by Dr. Scott Tagawa, MD, MS, FACP From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Scott Tagawa, MD, MS, FACP treated were cancer, hypertension, high cholesterol and ischemic heart disease.

Hypertension	54
High Cholesterol	44
Stroke	4
Ischemic Heart Disease	37
Depression	15
Chronic Kidney Disease	35
Asthma	6
Osteoporosis	9
Heart Failure	18
Chronic Obstructive Pulmonary Disease	8
Diabetes	24
Atrial Fibrillation	9
Cancer	59
Dementia	8

Education & Training

Dr. Scott Tagawa, MD, MS, FACP graduated from University of Southern California (USC), Keck School of Medicine. He completed residency at Los Angeles County+USC Medical Center. He is certified by the Hematology Internal Medicine Medical Oncology and has a state license in California.

Medical School: University of Southern California (USC), Keck School of Medicine

Residency: Los Angeles County+USC Medical Center

Board Certification: Hematology Internal Medicine Medical Oncology

Licensed In: California

Affiliations & Hospitals

Dr. Scott Tagawa, MD, MS, FACP is associated with these hospitals and organizations:

NewYork-Presbyterian

WEILL MEDICAL COLLEGE OF CORNELL

Multidisciplinary Prostate Cancer Clinic

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Scott Tagawa, MD, MS, FACP appears to accept the following insurance providers: AETNA, United Healthcare, Health Insurance Plan of NY (HIP), Oxford Health Plans, Empire Blue Cross/Blue Shield Healthplus, GHI, Aetna - NYP, Empire Blue Cross/Blue Shield, CIGNA, UnitedHealthcare, VNSNY CHOICE, Health Insurance Plan of New York (HIP), EmblemHealth, United Healthcare, Aetna, Oxford Health Plans, Empire BlueCross BlueShield and Group Health Incorporated (GHI).

Insurance Accepted by Provider includes:

According to our sources, Dr. Scott Tagawa, MD, MS, FACP accepts the following insurance providers:

AETNA

United Healthcare

Health Insurance Plan of NY (HIP)

Oxford Health Plans

Empire Blue Cross/Blue Shield Healthplus

GHI

Aetna - NYP

Empire Blue Cross/Blue Shield

CIGNA

UnitedHealthcare

VNSNY CHOICE

Health Insurance Plan of New York (HIP)

EmblemHealth

United Healthcare

Aetna

Oxford Health Plans

Empire BlueCross BlueShield

Group Health Incorporated (GHI)

Show More

Ratings & Reviews

Dr. Scott Tagawa, MD, MS, FACP does not have any reviews yet, be the first to leave a review of Dr. Scott Tagawa, MD, MS, FACP here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Scott Tagawa, MD, MS, FACP. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
GENZYME CORPORATION	$51,333 JEVTANA $50,552	NO PRODUCT DISCUSSED $781
Janssen Biotech, Inc.	$38,781 Erleada $24,352	ZYTIGA $5,921	Balversa $5,275	$3,234
Amgen Inc.	$28,941 XGEVA $16,065	NEUPOGEN $24	Neulasta $18	$12,833
Bayer HealthCare Pharmaceuticals Inc.	$25,950 Xofigo $13,141	Nubeqa $5,616	None $2,871	Nexavar $2,101	$2,222
Pfizer Inc.	$25,534 XTANDI $13,025	ORGOVYX $6,818	TALZENNA $5,200	$491
Other	$184,409 XTANDI $27,443	JEVTANA $14,150	Trodelvy $13,465	ILLUCCIX $12,009	Erleada $9,228	Other $108,114

**Types of Payments**
Consulting Fee	$209,112
Travel and Lodging	$68,208
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$36,972
Honoraria	$21,270
Food and Beverage	$16,261
Other	$3,125

Research Payments

Dr. Scott Tagawa, MD, MS, FACP has received 492 research payments totaling $9,411,968.

Biography

Dr. Scott Tagawa, who practices in New York, NY, is a medical specialist in medical oncology and hematology (blood disorders). He has a special interest in genitourinary cancer. Dr. Tagawa is affiliated with NewYork-Presbyterian. His practice in New York, NY is open to new patients as reported by Yext. He graduated from the University of Southern California (USC), Keck School of Medicine.